about
Development and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.Dextrin-colistin conjugates as a model bioresponsive treatment for multidrug resistant bacterial infections.The enhanced permeability retention effect: a new paradigm for drug targeting in infection.The antimicrobial effects of the alginate oligomer OligoG CF-5/20 are independent of direct bacterial cell membrane disruption.In Vitro Evaluation of the Interaction of Dextrin-Colistin Conjugates with Bacterial Lipopolysaccharide.Colistin past and future: a bibliographic analysis.Evaluation of hyaluronic acid-protein conjugates for polymer masked-unmasked protein therapy.Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug delivery.Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives.HPMA copolymer-phospholipase C and dextrin-phospholipase A2 as model triggers for polymer enzyme liposome therapy (PELT).Time-Resolved Small-Angle Neutron Scattering as a Tool for Studying Controlled Release from Liposomes using Polymer-Enzyme Conjugates.Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides.Controlled release of dextrin-conjugated growth factors to support growth and differentiation of neural stem cellsEvaluation of the physical and biological properties of hyaluronan and hyaluronan fragmentsPolymer Masked-Unmasked Protein Therapy: Identification of the Active Species after Amylase Activation of Dextrin-Colistin Conjugates
P50
Q35169065-87F308D4-F04A-4089-BD2A-1E9D466C7EECQ35382564-2678B8D5-1B4C-4394-BBD7-A8B15907BC0FQ38051263-43067F0F-6922-41E5-B339-F4496E278A91Q38288510-733CFC65-9CF6-49F0-AB6C-46129AF517F8Q38806547-397A293F-A82B-4A0F-9CA8-6A21262A30BCQ39591602-DBD1E9AA-FFEA-40F3-99F2-26A02745289CQ39648946-60E23353-ACBC-47B4-BA36-F82371C0EA52Q39951070-64F11B5E-2FF0-4EBA-BE4C-37B0A3CF5463Q40012286-369CA6A3-B90E-46DE-A72A-4159F4B9323FQ47946155-51C7E513-C7FE-4DA3-88D5-8C92B9FA844AQ50879676-EA063ACF-D242-4DA7-8117-D70F8F9B0D7AQ53425302-54BE0A5C-E494-48A7-8E2B-F35A738AE574Q55417581-44C61D55-BC58-48AD-B402-F48ECE944B15Q57482661-E62599EC-36EC-43B5-8DBD-527124832206Q84872417-033E19CA-00B1-4CB9-B16A-24AB85EB8C8FQ92269088-EB5C82CF-E408-4A82-9C84-DAA59FB39AAA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elaine L Ferguson
@ast
Elaine L Ferguson
@en
Elaine L Ferguson
@es
Elaine L Ferguson
@nl
type
label
Elaine L Ferguson
@ast
Elaine L Ferguson
@en
Elaine L Ferguson
@es
Elaine L Ferguson
@nl
prefLabel
Elaine L Ferguson
@ast
Elaine L Ferguson
@en
Elaine L Ferguson
@es
Elaine L Ferguson
@nl
P106
P1153
35785890000
P31
P496
0000-0002-0125-0234